Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme.

Diabetologia · 2020 · PMC7476973 · PMID 32776237

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

healthcare contacts and hospitalisations) in year 1 was negligible [ 17 ] and over the 2 years did not reach statistical significance; however, these cost savings were significant in year 2 (£521; 95% CI £12, £1085).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.